Original Data

Proteomic Identification and Immunolocalization of Increased Renal Calbindin-D28k Expression in OVE26 Diabetic Mice

Visith Thongboonkerd^1,2, Shirong Zheng³, Kenneth R. McLeish^1,4,5, Paul N. Epstein^3,6, Jon B. Klein^1,4,5

Keywords: proteomics, proteome, proteomic analysis, kidney, diabetic nephropathy, diabetes, calbindin-D28k, calcium, vitamin D, renal tubules

Abstract

Diabetic nephropathy is a common diabetic complication that is associated with alterations in the expression of several renal proteins and abnormal calcium homeostasis. We performed proteomic analysis to screen for global changes of renal protein expression in diabetic kidney. Proteins extracted from the whole kidney of 120-day-old OVE26 (a transgenic model of Type 1 diabetes) and FVB (non-diabetic background strain) mice were separated by two-dimensional polyacrylamide gel electrophoresis (2-D PAGE) and visualized by SYPRO Ruby staining (n = 5 in each group). Quantitative intensity analysis revealed 41 differentially expressed proteins, of which 30 were identified by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS) followed by peptide mass fingerprinting. One of the altered proteins with the greatest magnitude of change was the calcium-binding protein, calbindin-D28k, whose expression was increased 6.7-fold in diabetic kidney. We confirmed the increase in calbindin-D28k expression in diabetic kidney by Western blot analysis. Immunohistochemical study demonstrated that calbindin-D28k expression was markedly increased in tubular epithelial cells of distal convoluted tubules (DCT), collecting ducts (CD), and proximal convoluted tubules (PCT) in diabetic kidney. Calbindin-D28k plays a critical role in maintaining calcium homeostasis. The elevation in renal calbindin-D28k expression in our model may indicate a compensatory mechanism to overcome hypercalciuria in diabetes.

Fulltext: HTML , PDF (417KB)

This article has been cited by other articles:

	Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes Zhang D, Yang H, Kong X, Wang K, Mao X, Yan X, Wang Y, Liu S, Zhang X, Li J, Chen L, Wu J, Wei M, Yang J, Guan Y Am J Physiol Endocrinol Metab 2011. 300(2):E287-E295
	Urinary proteome analysis for early diagnosis of diabetes and its complications Zürbig P, Mischak H, Conrads S Diabetes Stoffwechsel Herz 2009. 18(6):483-494
	Do adenosine receptors offer new therapeutic options for diabetic nephropathy? Martin RS, Valladares D, Roa H, Troncoso E, Sobrevia L Curr Vasc Pharmacol 2009. 7(4):450-459
	Application of proteomic techniques to the study of urine and renal tissue Vilasi A, Cutillas PR, Unwin RJ Proteomics Clin Appl 2008. 2(12):1564-1574
	The urinary proteome in diabetes and diabetes-associated complications: New ways to assess disease progression and evaluate therapy Rossing K, Mischak H, Rossing P, Schanstra JP, Wiseman A, Maahs DM Proteomics Clin Appl 2008. 2(7-8):997-1007
	Proteomic studies in animal models of diabetes Resjo S, Berger K, Fex M, Hansson O Proteomics Clin Appl 2008. 2(5):654-669
	Outlook on Thailand's genomics and computational biology research and development Tongsima W, Tongsima S, Palittapongarnpim P PLoS Comput Biol 2008. 4(7):e1000115
	Searching for Novel Biomarkers and New Therapeutic Targets of Diabetic Nephropathy Using Proteomics Approaches Thongboonkerd V Contrib Nephrol 2008. 160:37-52
	Animal models of diabetes mellitus: relevance to vascular complications Thompson CS Curr Pharm Des 2008. 14(4):309-324
	Proteomics for diabetes research: an update and future perspectives Thongboonkerd V Expert Rev Endocr Metabol 2006. 1(4):507-515